EBS

News War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions

14d ago

News Why Emergent BioSciences Stock Plummeted Today

14d ago

News Why Emergent BioSolutions Stock Is Skyrocketing Today

14d ago

Insider trade Sale by Kathryn C Zoon

28d ago

Insider trade Sale by Donald W Degolyer

28d ago

Insider trade Sale by Keith Katkin

28d ago

Insider trade Sale by Sujata Tyagi Dayal

28d ago

News Emergent BioSolutions plummets on weak 2026 revenue guidance, Q4 results

95d ago

News Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances

95d ago

News Emergent BioSolutions authorizes $50 million stock repurchase program

95d ago

News Deadline Soon: DeFi Technologies Inc. (DEFT) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

123d ago

News BioAge Announces Pricing of Upsized $115.0 Million Public Offering

131d ago

News BioAge Announces Proposed Public Offering

132d ago

News BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026

133d ago

News ​Emergent BioSolutions (EBS) Receives a New Order from US Department of War

137d ago

News NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading

137d ago

News Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation

141d ago

Scanner Unusual volume (z=2.7)

160d ago